Behavioral Intervention
Physical Activity and Education for Colorectal Cancer
This trial is studying a physical activity program given together with health education materials to see how well it works compared with giving health education materials alone for patients who have undergone treatment for high-risk stage II or stage III colon cancer.
Selective Serotonin Reuptake Inhibitor
Fluoxetine for Anxiety and Depression
This trial uses fMRI to study brain regions engaged in processing motivationally salient stimuli in children, adolescents, and adults with mood and anxiety disorders, in order to better understand how these disorders develop and how they can be treated.
Ultrasound Therapy
Focused Ultrasound Neuromodulation for Affective Disorders
This trial is testing a new treatment using sound waves to target a part of the brain in people with emotional disorders like depression and anxiety. The treatment aims to change how this part of the brain works to improve symptoms. It is non-invasive and uses MRI to monitor changes in the brain.
Behavioural Intervention
TEAMSS Program for Anxiety Disorders
This trial aims to develop and test a program called TEAMSS to help students with anxiety transition successfully to middle school. The program will focus on reducing anxiety and improving academic performance. The study will involve expert
Behavioural Intervention
Structured Games/Playgroup for Childhood Anxiety
This trial is testing if the Camp Kidpower training, which uses either structured games or a playgroup, can lower anxiety in preschool age children. The study will look at parts of the brain as well as behaviors related to effortful control and fear, before and after training, to see if Kidpower helps kids stay in charge of their behaviors and emotions.
Popular Filters
Trials for Social Anxiety Disorder Patients
Behavioral Intervention
Exposure Therapy for Child Anxiety
This trial will compare the effectiveness of three different types of treatment for anxiety disorders in children and adolescents. The three types of treatment are cognitive behavioral therapy with exposure (CBT), patient-centered telehealth CBT (PCT-CBT; patient-centered telehealth closed as of 5/1/21), and traditional outpatient CBT. The trial will involve 379 participants who will be randomly assigned to one of the three treatment groups. The primary outcome measures will be the changes in the participants' anxiety symptoms, functioning, and quality of life from baseline to follow-up.
Behavioural Intervention
Behavioral Activation and Exposure Therapy for Anxiety and Depression in Youth
This trial will compare the effectiveness of different psychological treatments for anxiety and depression in youth, as well as how well each treatment works to change specific aspects related to the disorders.
Behavioral Intervention
Cognitive Behavioural Skills Training for Anxiety Disorders
"This trial aims to test a new program that helps parents with anxiety disorders learn coping skills to prevent their children from developing anxiety disorders. The goal is to intervene early and help children lead happy and healthy lives
Trials for Anxiety Disorders Patients
Nonsteroidal Anti-inflammatory Drug
Naproxen Sodium for OCD in PANDAS
This trial tests Naproxen Sodium, an anti-inflammatory drug, to see if it can reduce OCD symptoms in children with PANDAS. These children have OCD symptoms linked to inflammation from streptococcal infections. The medication aims to lower inflammation, potentially easing their symptoms.
Behavioral Intervention
Exposure Therapy for Child Anxiety
This trial will compare the effectiveness of three different types of treatment for anxiety disorders in children and adolescents. The three types of treatment are cognitive behavioral therapy with exposure (CBT), patient-centered telehealth CBT (PCT-CBT; patient-centered telehealth closed as of 5/1/21), and traditional outpatient CBT. The trial will involve 379 participants who will be randomly assigned to one of the three treatment groups. The primary outcome measures will be the changes in the participants' anxiety symptoms, functioning, and quality of life from baseline to follow-up.
Behavioural Intervention
Behavioral Activation and Exposure Therapy for Anxiety and Depression in Youth
This trial will compare the effectiveness of different psychological treatments for anxiety and depression in youth, as well as how well each treatment works to change specific aspects related to the disorders.
Phase 3 Trials
Atypical Antipsychotic
Quetiapine XR for Schizophrenia
This research will explore whether Quetiapine XR used primarily to treat psychosis may also cover for comorbid anxiety disorder and offer advantages in patients with schizophrenia and comorboid anxiety disorder. Preliminary data on pharmacological properties of Quetiapine and its metabolites and intuitive impression from our clinical experience lead to believe that Seroquel XR use in monotherapy may offer advantages over other antipsychotics in treating co-morbid anxiety disorder in patients suffering from schizophrenia. This open label switch study conducted in a schizophrenic population intends to verify this hypothesis.
Behavioural Intervention
BNC210 for Social Anxiety Disorder
This trial aims to see if a one-time dose of BNC210 can help reduce anxiety in adults with social anxiety disorder during a behavioral assessment. They will measure anxiety levels using a scale called the Subject
Behavioural Intervention
Fasedienol Nasal Spray for Social Anxiety Disorder
"This trial will test the effectiveness, safety, and tolerance of a nasal spray called Fasedienol in reducing anxiety symptoms in adults aged 18-65 with Social Anxiety Disorder. The study will also
Behavioural Intervention
SEP-363856 for Generalized Anxiety Disorder
This trial is testing a new medication called SEP-363856 to see if it can help adults aged 18-65 with Generalized Anxiety Disorder. The medication is taken daily and aims to reduce anxiety symptoms.
Trials With No Placebo
Behavioral Intervention
Exposure Therapy for Child Anxiety
This trial will compare the effectiveness of three different types of treatment for anxiety disorders in children and adolescents. The three types of treatment are cognitive behavioral therapy with exposure (CBT), patient-centered telehealth CBT (PCT-CBT; patient-centered telehealth closed as of 5/1/21), and traditional outpatient CBT. The trial will involve 379 participants who will be randomly assigned to one of the three treatment groups. The primary outcome measures will be the changes in the participants' anxiety symptoms, functioning, and quality of life from baseline to follow-up.
Behavioural Intervention
Behavioral Activation and Exposure Therapy for Anxiety and Depression in Youth
This trial will compare the effectiveness of different psychological treatments for anxiety and depression in youth, as well as how well each treatment works to change specific aspects related to the disorders.
Behavioral Intervention
Cognitive Behavioural Skills Training for Anxiety Disorders
"This trial aims to test a new program that helps parents with anxiety disorders learn coping skills to prevent their children from developing anxiety disorders. The goal is to intervene early and help children lead happy and healthy lives
Personality-Targeted Interventions for Substance Abuse
This trial will help researchers understand if a personality-targeted intervention, in addition to regular treatment, can help reduce alcohol and illicit drug use in adolescents with mental health problems.
View More Related Trials
Frequently Asked Questions
Introduction to anxiety disorder
What are the top hospitals conducting anxiety disorder research?
When it comes to advancing our understanding and treatment of anxiety disorders, several top hospitals are leading the way with their groundbreaking clinical trials. Massachusetts General Hospital in Boston, a renowned institution in mental health research, currently has four active trials focused on anxiety disorders. Their dedication to this field is evident through their impressive track record of 31 completed trials since recording their first study back in 2003. Meanwhile, the Michael E. DeBakey VA Medical Center located in Houston, Texas is making significant contributions as well with three ongoing anxiety disorder trials and a total of six completed studies since initiating their first trial in 2002.
In New york City, The Medical Research Network LLC is actively involved in three anxiety disorder trials that aim to provide new insights into this complex condition. While they may have fewer overall trials compared to other institutions (with only four recorded), their commitment towards cutting-edge research shines through despite joining the field more recently with their initial trial taking place just ten years ago in 2011.
North of the border, Toronto Western Hospital plays an important role by currently conducting two active clinical trials centered around anxiety disorders. Although they may be relatively new to exploring these specific conditions (having commenced their inaugural trial slated for completion in2023) there is no denying the potential impact they can make towards improving outcomes for individuals affected by such disorders
Lastly but not leastly,in Kingston Ontario; Kingston Health Sciences Centre has joined efforts focusing anxieties debilitating effects via participating on present-day's two promising clinical endeavors while also having been committed enough earlier when holding previous pair investigations during year2009.
These remarkable hospitals symbolize true pillars within psychiatric research; propelling advancements that pave pathways toward better diagnosis methods enhanced therapeutic approaches which ultimately promises brighter future where millions living with anxieties could obtain relief from distresses associated with aforementioned conditions
Which are the best cities for anxiety disorder clinical trials?
When it comes to anxiety disorder clinical trials, several cities emerge as leading centers for research and development. Boston, Massachusetts tops the list with 11 active trials investigating various interventions like Daylight dCBT Application, Naproxen Sodium, and IntelliCare with Automated Motivational Messaging and Coach Support. Following closely behind are Houston, Texas and New york City, both offering 8 ongoing studies exploring treatments such as iTCBT-I (Intensive Transdiagnostic Cognitive Behavioral Therapy-Individual), Structured games, Clinician-delivered CBT + Supplemental app, and Cariprazine. Toronto in Ontario also shows promise with 7 active trials examining interventions like Physical Activity Program + General Health Education Materials and Group 1: VR-ET. Lastly, Austin, Texas showcases 5 active trials focused on interventions including Focused ultrasound and Interoceptive Exposure. These cities serve as beacons of hope for individuals seeking innovative approaches to managing anxiety disorders through participation in clinical trials that pave the way for improved treatment options.
Which are the top treatments for anxiety disorder being explored in clinical trials?
Clinical trials are continuously exploring new avenues to find effective treatments for anxiety disorders. One treatment that shows promise is Omnis Salutis, currently being investigated in one active trial specifically dedicated to anxiety disorder. Although it has only recently been listed in 2023 and has a limited number of trials thus far, the potential benefits it may offer individuals struggling with anxiety make it an exciting area of research. As we delve deeper into these clinical trials, we hope to uncover groundbreaking advancements that will bring relief to those affected by anxiety disorders worldwide.
What are the most recent clinical trials for anxiety disorder?
Exciting developments in the field of anxiety disorder research have yielded promising clinical trials. Inositol, a substance undergoing Phase 1 and Phase 2 studies, has shown potential as a treatment option for individuals with anxiety disorders. Another trial focuses on ABBV-932, which is currently in Phase 1 testing and aims to evaluate its efficacy in managing anxiety disorder symptoms. Additionally, ENX-102 is being investigated during its Phase 2 stage to determine its suitability as an intervention for anxiety disorders. The use of cannabidiol is also under scrutiny through a Phase 4 study to explore its effects on alleviating anxiety disorder symptoms. Finally, SEP-363856's phases 2 and 3 are underway to assess this compound's effectiveness against these debilitating conditions. These exciting advancements provide hope for improved treatments that can enhance the lives of those impacted by anxiety disorders.
What anxiety disorder clinical trials were recently completed?
Recent clinical trials have made significant progress in the field of anxiety disorder research. In May 2022, Receptor Life Sciences concluded a trial investigating the effectiveness of Low dose RLS103 therapy. Likewise, Bionomics Limited completed their study on the potential benefits of 225 mg BNC210 in February 2022. The year prior, VistaGen Therapeutics successfully wrapped up their trial on PH94B Nasal Spray in May 2021. These studies demonstrate ongoing efforts to advance our understanding and treatment options for individuals living with anxiety disorders.